These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1475045)

  • 21. The binding of a Fos/Jun heterodimer can completely disrupt the structure of a nucleosome.
    Ng KW; Ridgway P; Cohen DR; Tremethick DJ
    EMBO J; 1997 Apr; 16(8):2072-85. PubMed ID: 9155033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
    Chen L; Glover JN; Hogan PG; Rao A; Harrison SC
    Nature; 1998 Mar; 392(6671):42-8. PubMed ID: 9510247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
    Ryseck RP; Bravo R
    Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SRY protein enhances transcription of Fos-related antigen 1 promoter constructs.
    Cohen DR; Sinclair AH; McGovern JD
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4372-6. PubMed ID: 8183916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Okadaic acid stimulated TRE binding activity in a papilloma producing mouse keratinocyte cell line involves increased AP-1 expression.
    Rosenberger SF; Bowden GT
    Oncogene; 1996 Jun; 12(11):2301-8. PubMed ID: 8649769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SP3 and AP-1 mediate transcriptional activation of the lamin A proximal promoter.
    Muralikrishna B; Parnaik VK
    Eur J Biochem; 2001 Jul; 268(13):3736-43. PubMed ID: 11432740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic AMP stimulates a JunD/Fra-2 AP-1 complex and inhibits the proliferation of interleukin-6-dependent cell lines.
    Rezzonico R; Loubat A; Lallemand D; Pfarr CM; Far DF; Proudfoot A; Rossi B; Ponzio G
    Oncogene; 1995 Sep; 11(6):1069-78. PubMed ID: 7566966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.
    Berger A; Rosenthal D; Spiegel S
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5885-9. PubMed ID: 7597047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fos and Jun bend the AP-1 site: effects of probe geometry on the detection of protein-induced DNA bending.
    Kerppola TK
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10117-22. PubMed ID: 8816761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-fos mediated stimulation of an AP-1 DNA binding activity in undifferentiated teratocarcinoma cell lines.
    Caceres J; Glikin G; Bravo R; Weinmann R
    Oncogene; 1990 Jan; 5(1):59-67. PubMed ID: 2157182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFβ1 through interactions with c-Jun and SP1.
    Gao P; Li L; Ji L; Wei Y; Li H; Shang G; Zhao Z; Chen Q; Jiang T; Zhang N
    Biochim Biophys Acta; 2014 Nov; 1839(11):1110-20. PubMed ID: 25046864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.
    Bohmann D; Bos TJ; Admon A; Nishimura T; Vogt PK; Tjian R
    Science; 1987 Dec; 238(4832):1386-92. PubMed ID: 2825349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative interaction between Ets and AP-1 transcription factors regulates induction of glutathione S-transferase Ya gene expression.
    Bergelson S; Daniel V
    Biochem Biophys Res Commun; 1994 Apr; 200(1):290-7. PubMed ID: 8166697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible role for the FosB/JunD AP-1 transcription factor complex in glutamate-mediated excitotoxicity in cultured cerebellar granule cells.
    Lidwell K; Griffiths R
    J Neurosci Res; 2000 Nov; 62(3):427-39. PubMed ID: 11054812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells.
    Marti A; Jehn B; Costello E; Keon N; Ke G; Martin F; Jaggi R
    Oncogene; 1994 Apr; 9(4):1213-23. PubMed ID: 8134124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.